TY - JOUR AU - Klein-Weigel, P. F. AU - Richter, J. G. PY - 2014 DA - 2014// TI - Thromboangiitis obliterans (Buerger’s disease) JO - Vasa VL - 43 UR - https://doi.org/10.1024/0301-1526/a000371 DO - 10.1024/0301-1526/a000371 ID - Klein-Weigel2014 ER - TY - JOUR AU - Rivera-Chavarría, I. J. AU - Brenes-Gutiérrez, J. D. PY - 2016 DA - 2016// TI - Thromboangiitis obliterans (Buerger’s disease) JO - Ann Med Surg VL - 7 UR - https://doi.org/10.1016/j.amsu.2016.03.028 DO - 10.1016/j.amsu.2016.03.028 ID - Rivera-Chavarría2016 ER - TY - STD TI - Sun XL, Law BY, de Seabra Rodrigues Dias IR, Mok SWF, He YZ, Wong VK. Pathogenesis of thromboangiitis obliterans: gene polymorphism and immunoregulation of human vascular endothelial cells. Atherosclerosis. 2017;265:258–65. ID - ref3 ER - TY - JOUR AU - Dellalibera-Joviliano, R. AU - Joviliano, E. E. AU - Silva, J. S. AU - Evora, P. R. B. PY - 2012 DA - 2012// TI - Activation of cytokines corroborate with development of inflammation and autoimmunity in thromboangiitis obliterans patients JO - Clin Exp Immunol VL - 170 UR - https://doi.org/10.1111/j.1365-2249.2012.04624.x DO - 10.1111/j.1365-2249.2012.04624.x ID - Dellalibera-Joviliano2012 ER - TY - JOUR AU - Ketha, S. S. AU - Cooper, L. T. PY - 2013 DA - 2013// TI - The role of autoimmunity in thromboangiitis obliterans (Buerger’s disease) JO - Ann N Y Acad Sci VL - 1285 UR - https://doi.org/10.1111/nyas.12048 DO - 10.1111/nyas.12048 ID - Ketha2013 ER - TY - JOUR AU - Gao, F. AU - Chiu, S. M. AU - Motan, D. A. L. AU - Zhang, Z. AU - Chen, L. AU - Ji, H. -. L. PY - 2016 DA - 2016// TI - Mesenchymal stem cells and immunomodulation: current status and future prospects JO - Cell Death Dis VL - 7 UR - https://doi.org/10.1038/cddis.2015.327 DO - 10.1038/cddis.2015.327 ID - Gao2016 ER - TY - JOUR AU - Gupta, P. K. AU - Krishna, M. AU - Chullikana, A. AU - Desai, S. AU - Murugesan, R. AU - Dutta, S. PY - 2017 DA - 2017// TI - Administration of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells in critical limb ischemia due to Buerger’s disease: phase ii study report suggests clinical efficacy JO - Stem Cells Transl Med VL - 6 UR - https://doi.org/10.5966/sctm.2016-0237 DO - 10.5966/sctm.2016-0237 ID - Gupta2017 ER - TY - JOUR AU - Ra, J. C. AU - Jeong, E. C. AU - Kang, S. K. AU - Lee, S. J. AU - Choi, K. H. PY - 2017 DA - 2017// TI - A prospective, nonrandomized, no placebo-controlled, phase I/II clinical trial assessing the safety and efficacy of intramuscular injection of autologous adipose tissue-derived mesenchymal stem cells in patients with severe Buerger’s disease JO - Cell Med VL - 9 UR - https://doi.org/10.3727/215517916X693069 DO - 10.3727/215517916X693069 ID - Ra2017 ER - TY - JOUR AU - Luger, D. AU - Lipinski, M. J. AU - Westman, P. C. AU - Glover, D. K. AU - Dimastromatteo, J. AU - Frias, J. C. PY - 2017 DA - 2017// TI - Intravenously-delivered mesenchymal stem cells: systemic anti-inflammatory effects improve left ventricular dysfunction in acute myocardial infarction and ischemic cardiomyopathy JO - Circ Res VL - 120 UR - https://doi.org/10.1161/CIRCRESAHA.117.310599 DO - 10.1161/CIRCRESAHA.117.310599 ID - Luger2017 ER - TY - JOUR AU - Sánchez-Guijo, F. AU - Caballero-Velázquez, T. AU - López-Villar, O. AU - Redondo, A. AU - Parody, R. AU - Martínez, C. PY - 2014 DA - 2014// TI - Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease JO - Biol Blood Marrow Transplant VL - 20 UR - https://doi.org/10.1016/j.bbmt.2014.06.015 DO - 10.1016/j.bbmt.2014.06.015 ID - Sánchez-Guijo2014 ER - TY - JOUR AU - Wang, J. AU - Liao, L. AU - Wang, S. AU - Tan, J. PY - 2013 DA - 2013// TI - Cell therapy with autologous mesenchymal stem cells—how the disease process impacts clinical considerations JO - Cytotherapy VL - 15 UR - https://doi.org/10.1016/j.jcyt.2013.01.218 DO - 10.1016/j.jcyt.2013.01.218 ID - Wang2013 ER - TY - JOUR AU - Nicolaï, S. P. A. AU - Kruidenier, L. M. AU - Rouwet, E. V. AU - Graffius, K. AU - Prins, M. H. AU - Teijink, J. A. W. PY - 2009 DA - 2009// TI - The walking impairment questionnaire: an effective tool to assess the effect of treatment in patients with intermittent claudication JO - J Vasc Surg VL - 50 UR - https://doi.org/10.1016/j.jvs.2008.12.073 DO - 10.1016/j.jvs.2008.12.073 ID - Nicolaï2009 ER - TY - JOUR AU - Rabin, R. AU - De Charro, F. PY - 2001 DA - 2001// TI - EQ-5D: a measure of health status from the EuroQol Group JO - Ann Med VL - 33 UR - https://doi.org/10.3109/07853890109002087 DO - 10.3109/07853890109002087 ID - Rabin2001 ER - TY - JOUR AU - Muntión, S. AU - Sánchez-Guijo, F. M. AU - Carrancio, S. AU - Villarón, E. AU - López, O. AU - Diez-Campelo, M. PY - 2012 DA - 2012// TI - Optimisation of mesenchymal stromal cells karyotyping analysis: implications for clinical use JO - Transfus Med VL - 22 UR - https://doi.org/10.1111/j.1365-3148.2012.01134.x DO - 10.1111/j.1365-3148.2012.01134.x ID - Muntión2012 ER - TY - STD TI - Coutinho T, Rooke TW, Kullo IJ. Arterial dysfunction and functional performance in patients with peripheral artery disease: a review. Vasc Med. 2011;16:203–11. ID - ref15 ER - TY - STD TI - de Witte SFH, Luk F, Sierra Parraga JM, Gargesha M, Merino A, Korevaar SS, et al. Immunomodulation by therapeutic mesenchymal stromal cells (MSC) is triggered through phagocytosis of MSC by monocytic cells. Stem Cells. 2018;36:602–15. ID - ref16 ER - TY - JOUR AU - Amorin, B. AU - Alegretti, A. P. AU - Valim, V. AU - Pezzi, A. AU - Laureano, A. M. AU - da Silva, M. A. L. PY - 2014 DA - 2014// TI - Mesenchymal stem cell therapy and acute graft-versus-host disease: a review JO - Hum Cell VL - 27 UR - https://doi.org/10.1007/s13577-014-0095-x DO - 10.1007/s13577-014-0095-x ID - Amorin2014 ER - TY - JOUR AU - Zhao, Q. AU - Ren, H. AU - Han, Z. PY - 2016 DA - 2016// TI - Mesenchymal stem cells: immunomodulatory capability and clinical potential in immune diseases JO - J Cell Immunother VL - 2 UR - https://doi.org/10.1016/j.jocit.2014.12.001 DO - 10.1016/j.jocit.2014.12.001 ID - Zhao2016 ER - TY - JOUR AU - Galderisi, U. AU - Squillaro, T. AU - Peluso, G. PY - 2016 DA - 2016// TI - Clinical trials with mesenchymal stem cells: an update JO - Cell Transplant VL - 25 UR - https://doi.org/10.3727/096368915X689622 DO - 10.3727/096368915X689622 ID - Galderisi2016 ER -